THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
THRX
Delisted
THRX was delisted on the 13th of February, 2024.
51 hedge funds and large institutions have $102M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
–
Holders Change %
0%
% of All Funds
0.88%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
2
Increased
17
Reduced
12
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.09M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$652K |
| 3 |
BlackRock
New York
|
+$512K |
| 4 |
Walleye Capital
New York
|
+$277K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$181K |
